- Open Access
Tetramethylpyrazine exerts a protective effect against injury from acute myocardial ischemia by regulating the PI3K/Akt/GSK-3β signaling pathway
Cellular & Molecular Biology Letters volume 24, Article number: 17 (2019)
We investigated the protective effect of tetramethylpyrazine (TMP) on injury related to acute myocardial ischemia (AMI) induced by isoproterenol (ISO).
Materials and methods
Rats were randomly assigned to five groups: control, ISO, ISO + propranolol (10 mg/kg), ISO + TMP (10 mg/kg) and ISO + TMP (20 mg/kg). The rats in the three ISO + groups were pretreated with propranolol or TMP, while the rats in the control and ISO groups were pretreated with an equal volume of saline. Afterwards, the rats in the four administration groups were subcutaneously injected with ISO for two consecutive days. The levels of creatine kinase (CK), lactate dehydrogenase (LDH), superoxide dismutase (SOD), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and IL-1β in the serum were measured using ELISA. The expressions of B-cell lymphoma-associated X-2 (Bax-2), B-cell lymphoma-2 (Bcl-2), phosphoinositide-3-kinase (PI3K), protein kinase B (Akt), glycogen synthase kinase 3β (GSK-3β), MDA5 and SOD1 were determined using western blotting assay. The phosphorylation of PI3K, Akt and GSK-3β were also determined using western blotting assay. The left ventricles of the rats were extracted and stained using hematoxylin and eosin (H&E). The ST segment was recorded using electrocardiograms (ECGs).
Administration of TMP (10, 20 mg/kg) reduced the levels of MDA and CK and the activities of SOD and LDH in the serum. Pretreatment with TMP significantly reduced the levels of pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α. Treatment with TMP also improved the histopathological alteration and decreased the ST elevation. Furthermore, TMP ameliorated the expressions of Cu, SOD1, MDA5, Bax-2, Bcl-2, p-PI3K, p-Akt and p-GSK-3β in ISO-induced rats.
Tetramethylpyrazine protected against injury due to AMI by regulating the PI3K/Akt /GSK-3β signaling pathway.
The leading cause of morbidity in the Western world is acute myocardial ischemia (AMI), which is caused by an imbalance between the blood supply to the heart and the demand of the myocardium [1, 2]. The primary features of AMI are hypoxia, cell ischemia and inflammation. Obstruction of the blood flow to the heart contributes to the ischemia of myocardial cells, which may contribute to the apoptotic process [3,4,5]. Despite significant research and clinical advances, there have been no fundamental breakthroughs in drug treatment .
Isoproterenol (ISO), a β-adrenergic agonist, is known to induce AMI due to autoxidation-related free radical production . ISO-induced AMI increases the levels of cardiac enzymes and oxidative stress, and results in abnormal electrocardiograph and cardiac functions .
Although the pathogenesis of AMI is far from clear, the anatomical changes and biochemical markers have been well characterized. Overproduction of reactive oxygen species (ROS) and activation of inflammatory cascades are the major causative factors of cardiomyocyte abnormalities [9, 10]. Activation of the pro-survival kinase-signaling cascade phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) promotes cell survival and recruits the anti-apoptotic pathway during reperfusion [11, 12].
Experimental studies have indicated that intervention and ischemia preconditioning using some pharmacological agents can recruit the PI3K/Akt pathway and confer powerful cardioprotection . It has been proposed that pharmacological targeting of the Akt pathway may potentially diminish ischemia reperfusion (IR) injury .
Glycogen synthase kinase-3β (GSK-3β) belongs to a family of conserved serine/threonine kinases. Its activity is regulated by the PI3K/Akt, extracellular signal-regulated kinase (ERK1/2) and Wnt/wingless signaling pathways, among others . GSK-3β phosphorylation at Ser9 causes its N-terminal protein tail to act as a pre-phosphorylated substrate, leading to GSK-3β inactivation . The selective inhibition of GSK-3β has been shown to exert cardioprotective effects by maintaining mitochondrial function during ischemia/reperfusion injury .
Tetramethylpyrazine (TMP) is an alkaloid found in the roots of Ligusticum chuanxiong Hort (Fig. 1) . It has cardioprotective effects against myocardial IR injury: it limits infarct size and reduces apoptosis . In this study, we further investigated the cardioprotective effect of TMP and assessed whether the PI3K/Akt/GSK-3β signal pathway was involved in the cardioprotective effect of TMP.
Materials and methods
This study was performed in accordance with the National Institutes of Health Guidelines for the Use of Laboratory Animals. Male Sprague-Dawley (SD) rats (200–220 g) were provided by Shanghai Slac Laboratory Animal Co. Ltd. All animals were allowed free access to food and water, and were maintained at 22–24 °C under a 12 h:12 h light–dark cycle.
Tetramethylpyrazine (TMP; Fig. 1) and isoproterenol (ISO) were obtained from National Institutes for Food and Drug Control in Beijing. Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and IL-1β ELISA kits, creatine kinase (CK), lactate dehydrogenase (LDH), and ELISA kits for the detections of malondialdehyde (MDA) and total superoxide dismutase (T-SOD) were produced by Jiancheng Bioengineering Institute.
Rats were randomly assigned to the control group and four administration groups: ISO, ISO + propranolol (10 mg/kg), ISO + TMP (10 mg/kg), and ISO + TMP (20 mg/kg). There were 10 rats in each group. The rats in the three ISO + groups were pretreated with propranolol or TMP, while the rats in the control and ISO groups were treated with equal volumes of normal saline. Afterwards, the rats in all four administration groups were subcutaneously injected with ISO (85 mg/kg) for two consecutive days . Blood (3 ml) was collected from the abdominal aorta for serum enzyme assays. After treatment, three hearts from each group were weighed and applied for the western blotting assay. Three hearts from each group were rinsed in ice-cold isotonic saline, blotted with filter paper, and homogenized in 0.05 M ice-cold phosphate buffer (pH 7.4) for biochemical assays.
Evaluation of ST segment elevation
Electrocardiograms (ECGs) recorded ST segment elevation 24 h after the final injection of ISO or other drugs. ECGs were recorded under 3% chloral hydrate anesthesia using needle electrodes and a BL-420S Biological Function Experiment System purchased from Chengdu Thaimeng Technology Co. Ltd.
Calculation of the heart weight index
The heart tissues were weighed after blotting with filter paper. The heart weight index (HWI) was calculated as heart weight (HW)/bodyweight (BW).
Determinations of CK, LDH, SOD, MDA, TNF-α, IL-6 and IL-1β in serum
Blood samples were collected from the carotid artery and centrifuged at 3500 rpm for 15 min. Then the supernatants were obtained and preserved at − 80 °C for serum enzyme assays and cytokine analyses. IL-6, IL-1β and TNF-α were analyzed using ELISA kits. The levels of CK, LDH, SOD and MDA were measured using a rate assay. All measurements were performed according to the kit manufacturers’ instructions.
Histological examination of the myocardium
Immediately after removal, the hearts were fixed in 10% formalin solution. The heart tissue was processed for sectioning and staining using standard histological methods. Sections from the left ventricle were stained using hematoxylin and eosin (H&E).
Total proteins were extracted from myocardial tissues using ice-cold RIPA lysis buffer. Dissolved proteins were collected and the debris was removed via centrifugation at 12,000 rpm for 5 min at 4 °C. The concentration of total protein was determined using bicinchoninic acid protein assay reagent. Equal amounts of isolated protein were loaded on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto the polyvinylidene difluoride (PVDF) membrane. The membranes were incubated at 4 °C overnight with 5% skim milk in Tris buffer saline for blocking. After the membranes were blocked, they were incubated with monoclonal antibodies against Bax-2, Bcl-2, PI3K, Akt, GSK-3β, p-PI3K, p-Akt, p-GSK-3β, MDA5, SOD1 and GAPDH (all from Cell Signaling Technology). After washing with TBST three times, they were incubated with horseradish peroxidase-conjugated IgGs (1:10000; Bioworld Biotechnology) for 1 h at room temperature. Target proteins were detected using the ECL system (Millipore) and visualized with the ChemiDoc XRS system (Bio-Rad).
Each experiment was repeated at least three times. Data are shown as the means ± standard deviation, and were analyzed using SPSS 18.0. Statistical comparisons between groups were analyzed using two-tailed Student’s t test or one-way ANOVA. p < 0.05 is considered to indicate a statistically significant difference.
TMP reduces ST segment elevation
In our study, the ST segment was dramatically elevated in the ISO-stimulated rats. These results suggest that the myocardial ischemia damage model was successfully established. However, the ST segment was obviously decreased in the groups treated with TMP or propranolol compared with those in the ISO group (Fig. 2).
TMP decreases the levels of TNF-α, IL-6 and IL-1β
We also found that the levels of the pro-inflammatory cytokines TNF-α, IL-6 and IL-1β in the serum were significantly increased in ISO rats compared with the control group. However, pretreatment with TMP decreased the levels of TNF-α, IL-6 and IL-1β relative to the levels for untreated rats in a dose-dependent manner (Fig. 3).
TMP decreases CK and LDH serum levels
The serum levels of CK and LDH, which are marker enzymes of myocardial injury, were also examined. The levels of CK and LDH increased in the ISO group in comparison with those in the control group (Fig. 4a and b). Propranolol could decrease the contents of CK and LDH. Pretreatment with TMP decreased CK and LDH levels compared with the levels for rats in the ISO group in a dose-dependent manner.
TMP decreases SOD and MDA serum levels
To determine whether TMP attenuated the oxidation index, the levels of SOD and MDA in the serum were measured. Compared with the control group, SOD levels in the ISO group were significantly downregulated by TMP (Fig. 4c). However, pretreatment with TMP markedly increased the level of SOD (Fig. 4c) and reduced the MDA level (Fig. 4d) in a dose-dependent manner. These data suggest that TMP significantly enhanced the activities of the enzymatic antioxidant defense system.
TMP decreases heart weight indices
Heart weight indices (HWIs) were measured to assess injury due to acute myocardial ischemia (AMI). The HWIs for the ISO group rats were higher than those for the control group rats. Pretreatment with TMP decreased the HWIs compared with those for the ISO group rats (Fig. 5).
TMP attenuates the histopathological condition of myocardial tissue
Hematoxylin and eosin (H&E) staining was carried out to evaluate the protective role of TMP. Light microscopy of tissue sections from control rat myocardia showed a normal myofibrillar structure with striations, a branched appearance and continuity with adjacent myofibrils. The pathology assessment of the myocardia of ISO rats revealed obvious myocardial cell swelling, degeneration, transverse striation loss and inflammatory cell infiltration. Tissues from rats pretreated with TMP showed normal, well preserved cardiac muscle cell histology. Tissue sections from the propranolol group rats revealed approximately normal myofibrillar structure with clear transverse striations and the presence of a few inflammatory cells (Fig. 6). The results indicate that TMP could attenuate the histopathological condition in myocardial tissue.
TMP decreases the levels of MDA5 and increases the levels of SOD1
ISO also changed the protein expressions of SOD1 and MDA5 in heart tissue. Compared with the control group, the protein levels of MDA5 in the ISO group were significantly higher (Fig. 7). In the TMP-pretreated group, the protein levels of MDA5 were significantly lower. Compared with the control group, the protein levels of SOD1 in the ISO group were significantly lower. In the TMP-pretreated group, the protein levels of SOD1 were significantly higher than in the ISO group. The results confirmed the anti-oxidative effect of TMP on ISO-induced AMI.
TMP decreases Bax-2 levels and increases PI3K, Akt, GSK-3β and Bcl-2 levels
To further investigate the potential protective mechanism, the impact of TMP on PI3K/Akt/GSK-3β signaling was determined using western blotting assay. The expressions of Bcl-2, p-PI3K, p-Akt and p-GSK-3β in the myocardia of ISO rats were significantly downregulated in contrast with those in the control group (Fig. 8). In the TMP-pretreated group, the protein levels of Bcl-2, p-PI3K, p-Akt and p-GSK-3β significantly increased in a dose-dependent manner compared to the levels for the model group.
During acute myocardial ischemia (AMI), ST segment elevation is closely associated with myocardial blood flow, oxygen tension and the contraction rate. Myocardial ischemia induced by coronary artery ligation in rats shows very similar characteristics and can be used as a model of AMI . ST segment elevation is the most straightforward way to identify myocardial ischemia, as shown in the records of electrocardiographs (ECGs) in this study. In our tetramethylpyrazine (TMP) groups, the ST segment was effectively attenuated, suggesting that TMP has a positive influence on cardiac electrical activity.
Creatine kinase (CK) and lactate dehydrogenase (LDH) are identified as essential serum biomarkers for the diagnosis of AMI . The abnormal myocardial energy metabolism seen during AMI elevates the CK level in the serum . Myocardial necrosis enhances the membrane permeability that leads to excessive release of LDH . Our results show that TMP pretreatment potently reduced the levels of LDH and CK after MI was induced. These findings aligned with the histological evaluation of myocardial tissues.
Enhanced levels of inflammatory markers are related to ischemia [25, 26]. Pro-inflammatory cytokines, such as IL-6, IL-1β and TNF-α, are small secreted proteins that mediate and regulate inflammation . In our study, TMP decreased the levels of pro-inflammatory cytokines, suggesting that the cardioprotective effects were related to anti-inflammatory properties.
Superoxide dismutase (SOD) is an important antioxidant enzyme that reflects the capacity of the cell to scavenge free radicals . Under physiological conditions, low levels of reactive oxygen species play important roles in signal transduction and metabolic pathways. However, under pathological conditions, excessive reactive oxygen species result in an imbalance of the antioxidant system. It was proposed that malondialdehyde (MDA) caused injury to the mitochondria and lysosome . SOD1 scavenges superoxide anion to prevent oxygen stress injury and facilitates the generation of SOD . Similarly, the antioxidant protein MDA5 promotes the production of MDA. SOD1 gains importance in the development of heart failure. The alterations in SOD, SOD1, MDA and MDA5 levels support our hypothesis that the cardioprotective effects of TMP in ISO-induced AMI are related to anti-oxidative properties .
As part of the intrinsic apoptosis pathway, the Bcl-2 protein family is an important regulator during cardiomyocyte apoptosis . The anti-apoptotic protein, Bcl-2, and survivin have been shown to block the release of cytochrome c from the mitochondria, inhibit caspase activity, and decrease cell apoptosis . Therefore, the balance in apoptotic signaling is influenced by the Bcl-2-to-Bax ratio. Western blotting revealed that TMP increased Bcl-2 and decreased Bax-2 levels, suggesting that TMP-mediated cardioprotection against acute myocardial ischemia injury may occur partially via modulation of Bcl-2 and Bax expression.
Activation of the pro-survival kinase-signaling cascade PI3K/Akt at the time of reperfusion promotes cell survival and recruits the anti-apoptotic pathway during reperfusion . Experimental studies have indicated that the intervention and ischemia preconditioning of some pharmacological agents can recruit the PI3K/Akt pathway and confer powerful cardioprotection . The serine/threonine survival kinase GSK-3β is a point of downstream convergence for PI3K/Akt and Wnt signaling. It is known that ischemic pre- and post-conditioning activate PI3K/Akt and promote the phosphorylation of target molecules, such as GSK-3β, that are downstream of insulin receptor substrates . As depicted in Fig. 7, the expressions of Bax-2 in the myocardia of the ISO rats were significantly upregulated in contrast with those in control group. Compared with the control group, the protein levels of PI3K, Akt, GSK-3β and Bcl-2 in ISO group were significantly lower. In groups with TMP pretreatment, the protein levels of PI3K, Akt, GSK-3β and Bcl-2 significantly increased in a dose-dependent manner compared to the ISO group.
ISO-induced AMI could be attenuated by TMP through regulation of the inflammatory condition and oxidative stress. Our study also demonstrated that TMP exerted cardioprotective effects via regulation of the PI3K/Akt/GSK-3β pathway.
Acute myocardial ischemia
Hematoxylin and eosin
Tumor necrosis factor-alpha
Spartalis M, Voudris V, Iliopoulos DC, Spartalis E, Siasos G. Acute transient myocardial ischemia: a common pathophysiological mechanism in takotsubo syndrome. Is it still a cardiomyopathy? J Cardiol. 2018;72:176.
Li B, Hu J, Chen X. MicroRNA-30b protects myocardial cell function in patients with acute myocardial ischemia by targeting plasminogen activator inhibitor-1. Exp. Ther. Med. 2018;15:5125–32.
Kohlhauer M, Dawkins S, Costa ASH, Lee R, Young T, Pell VR, Choudhury RP, Banning AP, Kharbanda RK, Oxford Acute Myocardial Infarction S, Saeb-Parsy K, Murphy MP, Frezza C, Krieg T, Channon KM. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury. J Am Heart Assoc. 2018;7:e007546.
Sun Q, Shen ZY, Duan WN, Meng QT, Xia ZY. Mechanism of myocardial ischemia/reperfusion-induced acute kidney injury through DJ-1/Nrf2 pathway in diabetic rats. Exp. Ther. Med. 2017;14:4201–7.
Li X, Dai Y, Yan S, Shi Y, Han B, Li J, Cha L, Mu J. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochem Biophys Res Commun. 2017;491:1026–33.
Liang S, Ping Z, Ge J. Coenzyme Q10 regulates Antioxidative stress and autophagy in acute myocardial ischemia-reperfusion injury. Oxidative Med Cell Longev. 2017;2017:9863181.
Jia G, Zao M, Liu X. Protective effect of diethylcarbamazine inhibits NF-kappaB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway. Mol Med Rep. 2017;16:1596–602.
Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C. Isoproterenol-induced cardiac ischemia and fibrosis: plant-based approaches for intervention. Phytother Res. 2018;32:1908–32.
Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012;133:230–55.
Zhou T, Chuang CC, Zuo L. Molecular characterization of reactive oxygen species in myocardial ischemia-reperfusion injury. Biomed Res Int. 2015;2015:864946.
Wang ZG, Wang Y, Huang Y, Lu Q, Zheng L, Hu D, Feng WK, Liu YL, Ji KT, Zhang HY, Fu XB, Li XK, Chu MP, Xiao J. bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway. Sci Rep. 2015;5:9287.
Lv X, Xu T, Wu Q, Zhou Y, Huang G, Xu Y, Zhong G. 6-Gingerol activates PI3K/Akt and inhibits apoptosis to attenuate myocardial ischemia/reperfusion injury. Evidence-based complementary and alternative medicine : eCAM. 2018;2018:9024034.
Li X, Bilali A, Qiao R, Paerhati T, Yang Y. Association of the PPARgamma/PI3K/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic/reperfusion injury. Mol Med Rep. 2018;17:6759–67.
Zhang M, Gu WW, Hong XY. Involvement of endothelin 1 in remote preconditioning-induced Cardioprotection through connexin 43 and Akt/GSK-3beta signaling pathway. Sci Rep. 2018;8:10941.
Hu Z, Hu S, Yang S, Chen M, Zhang P, Liu J, Abbott GW. Remote liver ischemic preconditioning protects against sudden cardiac death via an ERK/GSK-3beta-dependent mechanism. PLoS One. 2016;11:e0165123.
Weng J, Wang YH, Li M, Zhang DY, Jiang BG. GSK3beta inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury. Neural Regen Res. 2018;13:324–30.
Jiang H, Xiao J, Kang B, Zhu X, Xin N, Wang Z. PI3K/SGK1/GSK3beta signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide. Exp Cell Res. 2016;345:134–40.
Wang A, Zhu G, Qian P, Zhu T. Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury. Exp. Ther. Med. 2017;14:2392–400.
Yang J, Li J, Lu J, Zhang Y, Zhu Z, Wan H. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia. J Ethnopharmacol. 2012;140:64–72.
Zheng P, Liu J, Mai S, Yuan Y, Wang Y, Dai G. Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats. Hum. Exp. Toxicol. 2015;34:538–47.
Deng XY, Chen JJ, Li HY, Ma ZQ, Ma SP, Fu Q. Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. Chem Biol Interact. 2015;240:22–8.
Khwaja S, Mahmood T, Siddiqui HH. Effect of ethanolic extract of Cyperus rotundus L against isoprenaline induced cardiotoxicity. Indian J. Exp. Biol. 2016;54:670–5.
Song Y, Zhang C, Wang C, Zhao L, Wang Z, Dai Z, Lin S, Kang H, Ma X. Ferulic acid against cyclophosphamide-induced heart toxicity in mice by inhibiting NF-kappaB pathway. Evid Based Complement Alternat Med. 2016;2016:1261270.
Zhang T, Yan T, Du J, Wang S, Yang H. Apigenin attenuates heart injury in lipopolysaccharide-induced endotoxemic model by suppressing sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Chem Biol Interact. 2015;233:46–55.
Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505–22.
Gasparyan AY. Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. Curr Pharm Des. 2012;18:1447–9.
Wang J, Hu Z, Yang S, Liu C, Yang H, Wang D, Guo F. Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit. Exp. Ther. Med. 2018;16:1014–20.
Jain PG, Mahajan UB, Shinde SD, Surana SJ. Cardioprotective role of FA against isoproterenol induced cardiac toxicity. Mol Biol Rep. 2018;45:1357–65.
Hermenean A, Ardelean A, Stan M, Herman H, Mihali CV, Costache M, Dinischiotu A. Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney. Chem Biol Interact. 2013;205:138–47.
Wei B, You MG, Ling JJ, Wei LL, Wang K, Li WW, Chen T, Du QM, Ji H. Regulation of antioxidant system, lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats. Atherosclerosis. 2013;230:148–56.
Gao J, Zhong MK, Fan ZD, Yuan N, Zhou YB, Zhang F, Gao XY, Zhu GQ. SOD1 overexpression in paraventricular nucleus improves post-infarct myocardial remodeling and ventricular function. Pflugers Archiv : European journal of physiology. 2012;463:297–307.
Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z, Wang Z. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int. J. Clin. Exp. Pathol. 2014;7:565–74.
Wang H, Li J, Chi H, Zhang F, Zhu X, Cai J, Yang X. MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells. J Cell Mol Med. 2015;19:2084–97.
Zhang C, Pan S, Aisha A, Abudoukelimu M, Tang L, Ling Y. Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes. Biochem Biophys Res Commun. 2018;503:1186–93.
Wang S, Zhu Y, Qiu R. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway. Biomed Pharmacother. 2018;104:712–7.
Ponnusamy A, Sinha S, Hyde GD, Borland SJ, Taylor RF, Pond E, Eyre HJ, Inkson CA, Gilmore A, Ashton N, Kalra PA, Canfield AE. FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis. PLoS One. 2018;13:e0196232.
The study was supported by the Key Project of Natural Science Research from Education Office of Sichuan province (No. 16ZA0230).
Availability of data and materials
Ethics approval and consent to participate
The research protocol was assessed and approved by the Ethics Committee (No: 20171009) of No.1 Hospital of Jilin University.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yang, Q., Huang, D.D., Li, D.G. et al. Tetramethylpyrazine exerts a protective effect against injury from acute myocardial ischemia by regulating the PI3K/Akt/GSK-3β signaling pathway. Cell Mol Biol Lett 24, 17 (2019). https://doi.org/10.1186/s11658-019-0141-5
- Myocardial ischemia